https://www.indianpharmapost.com/aurobindo-pharma-gets-approval-for-3-products-under-pli-scheme-icici-securities-74032021-01-26T13:24:00+05:30always0.9https://www.indianpharmapost.com/slow-recovery-in-biosimilars-for-biocon-icici-securities-74022021-01-26T13:19:00+05:30always0.9